Diana Cviič

1. CVIIČ, Diana. Preučevanje izražanja gena SREBF1 v nedrobnoceličnem pljučnem rakavem tkivu : diplomsko delo. Ljubljana: [D. Cviič], 2012. IX, 62 f., ilustr. [COBISS.SI-ID 36039685]

2. OSREDKAR, Joško, JAGARLAMUDI, K. K., CVIIČ, Diana, ŠKOF, Erik, CVJETIČANIN, Branko, ZORE, Andrej, LUKANOVIĆ, David, ERIKSSON, Staffan, MEGLIČ, Leon. Clinical significance of the TK1 specific activity in the early detection of ovarian cancer. Oncology. 2024, vol. 102, no 1, str. 17-29, ilustr. ISSN 1423-0232. https://karger.com/ocl/article-abstract/102/1/17/862519/Clinical-Significance-of-the-TK1-Specific-Activity, DOI: 10.1159/000533428. [COBISS.SI-ID 163920899]

3. CVIIČ, Diana, JAGARLAMUDI, K. K., MEGLIČ, Leon, ŠKOF, Erik, ZORE, Andrej, LUKANOVIĆ, David, ERIKSSON, Staffan, OSREDKAR, Joško. A dual biomarker TK1 protein and CA125 or HE4-based algorithm as a better diagnostic tool than ROMA Index in early detection of ovarian cancer. Cancers. 2023, vol. 15, iss. 5, art. 1593, 18 str., ilustr. ISSN 2072-6694. https://www.mdpi.com/2072-6694/15/5/1593, Repozitorij Univerze v Ljubljani – RUL, DiRROS - Digitalni repozitorij raziskovalnih organizacij Slovenije, DOI: 10.3390/cancers15051593. [COBISS.SI-ID 144061955]

4. CVIIČ, Diana, JAGARLAMUDI, K. K., MEGLIČ, Leon, ŠKOF, Erik, ZORE, Andrej, LUKANOVIĆ, David, OSREDKAR, Joško. STK1 concentration and STK1 activity as a diagnostic and prog nostic proliferation biomarker for ovarian cancer : [poster presentations]. V: OSREDKAR, Joško (ur.). Book of Abstracts : 46th ISOBM Congress 13th - 17th October, Bled, Slovenia. Basel: [S. Karger], 2023. Str. s65-s66. Tumor Biology (Online), Vol.46, iss. s1. ISSN 1010-4283. https://content.iospress.com/download/tumor-biology/tub239004?id=tumor-biology%2Ftub239004, DOI: 10.3233/TUB-239004. [COBISS.SI-ID 155353859]

5. CVIIČ, Diana. Timidin kinaza 1 kot diagnostični tumorski označevalec pri bolnicah z rakom jajčnikov = Thymidine kinase 1 as a diagnostic tumor marker in patients with ovarian cancer : doktorska disertacija. Ljubljana: [D. Cviič], 2023. XVI, 106 f., tabele, graf. prikazi, ilustr. [COBISS.SI-ID 176823555]

6. OSREDKAR, Joško, LUKANOVIĆ, David, ŠKOF, Erik, CVIIČ, Diana, JERIN, Aleš, MATJAŠIČ, Miha, MEGLIČ, Leon. Prognostic role of CA-125 elimination rate constant (KELIM) in patients with advanced epithelial ovarian cancer. V: Book of Abstracts : 47th Conference of the International Society of Oncology and Biomarkers, Murnau, Germany | October 13–16, 2025 : new Era of Biomarkers in Oncology. [S. l.]: [s. n.], 2025. Str. 26, o21. https://www.trillium.de/fileadmin/user_upload/Akademie/ISOBM/ISOBM_program_extended_web.pdf, https://www.trillium.de/en/academy/isobm-conference-2025/isobm-conference-program.html. [COBISS.SI-ID 254376963]

7. OSREDKAR, Joško, LUKANOVIĆ, David, ŠKOF, Erik, CVIIČ, Diana, JERIN, Aleš, MATJAŠIČ, Miha, MEGLIČ, Leon, ISOBM, Murnau 2025, 47th Conference of the International Society of Oncology and Biomarkers, Murnau, Germany, October 13–16, 2025. Prognostic role of CA-125 elimination rate constant (KELIM) in patientswith advanced epithelial ovarian cancer. Tumor biology. 2025, issue 1, suppl. , str. 26. ISSN 1423-0380. https://journals.sagepub.com/doi/epdf/10.1177/14230380251386526, DOI: 10.1177/14230380251386526. [COBISS.SI-ID 254355715]

8. LUKANOVIĆ, David, MEGLIČ, Leon, CVIIČ, Diana, JERIN, Aleš, LEŠNIK, Kaja, MATJAŠIČ, Miha, ŠKOF, Erik, OSREDKAR, Joško, ESGO 2026 Congress, 26-28 February 2026, Copenhagen, Denmark. Evaluating thymidine kinase as a biomarker of chemoresistance in epithelial ovarian cancer using the KELIM model. International journal of gynecological cancer. [Online ed.]. Feb. 2026, vol. 36, issue 2, suppl. 1, [article no.] 862, 103848, [1] str., ilustr. ISSN 1525-1438. https://www.international-journal-of-gynecological-cancer.com/article/S1048-891X(25)02972-X/fulltext, https://www.international-journal-of-gynecological-cancer.com/action/showPdf?pii=S1048-891X%2825%2902972-X, https://www.sciencedirect.com/science/article/pii/S1048891X2502972X, DOI: 10.1016/j.ijgc.2025.103848. [COBISS.SI-ID 270378755]

9. LUKANOVIĆ, David, OSREDKAR, Joško (avtor, korespondenčni avtor), ŠKOF, Erik, CVIIČ, Diana, JERIN, Aleš, LEŠNIK, Kaja, MATJAŠIČ, Miha, MEGLIČ, Leon. Thymidine kinase as a biomarker of chemoresistance in epithelial ovarian cancer using the KELIM model. Frontiers in pharmacology. 2026, vol. 17, [article no.] 1617484, 11 str., graf. prikazi, tabele. ISSN 1663-9812. https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1617484/full, Repozitorij Univerze v Ljubljani – RUL, DiRROS - Digitalni repozitorij raziskovalnih organizacij Slovenije, DOI: 10.3389/fphar.2026.1617484. [COBISS.SI-ID 276854531]
projekt: The author(s) declared that financial support was received for this work and/or its publication. Tertiary Research Project of the University Clinical Centre Ljubljana No.: 20190069.